Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
713700
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status and completion of exercise of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
713,700 new shares (number of shares issued in August 2026)
発行済株式総数
1.05% (exercise ratio relating to the exercise restrictions; the ratio of the shares exercised on this occasion to the number of issued common shares was not disclosed)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥63.5 or ¥64.4. The specific terms of the adjustment clause and the adjustment floor were Not disclosed
Number of Stock Acquisition Rights
As 7,137 stock acquisition rights, representing 5.25% of the total number issued, were exercised during the relevant month, the total number issued can be inferred to be approximately 135,943. However, the stated total number issued was Not disclosed. The number outstanding and unexercised at the end of the relevant month was 0.
Procedures under the Corporate Code of Conduct
The disclosure describes the company's compliance with Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments and Related Matters in connection with the exercise restrictions.
Most recent equity financing
23rd Series Stock Acquisition Rights issued on 25 December 2025 (with an exercise price adjustment clause). The amount was Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status and completion of exercise of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 713,700 new shares (number of shares issued in August 2026) |
| Dilution Rate | 1.05% (exercise ratio relating to the exercise restrictions; the ratio of the shares exercised on this occasion to the number of issued common shares was not disclosed) |
| Total number of issued shares | 81,150,000 shares (number of issued common shares as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | ¥63.5 or ¥64.4. The specific terms of the adjustment clause and the adjustment floor were Not disclosed |
| Number of Stock Acquisition Rights | As 7,137 stock acquisition rights, representing 5.25% of the total number issued, were exercised during the relevant month, the total number issued can be inferred to be approximately 135,943. However, the stated total number issued was Not disclosed. The number outstanding and unexercised at the end of the relevant month was 0. |
| Procedures under the Corporate Code of Conduct | The disclosure describes the company's compliance with Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments and Related Matters in connection with the exercise restrictions. |
| Most recent equity financing | 23rd Series Stock Acquisition Rights issued on 25 December 2025 (with an exercise price adjustment clause). The amount was Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company does not state a reason.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.